1. Research advances in HMGN5 and cancer
   Zhan Shi et al, 2016, Tumor Biology CrossRef
2. MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5
   Yidong Cao et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
3. New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
   Monika Świerczewska et al, 2018, Molecules CrossRef
4. Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression
   Jayu Jen et al, 2019, Cell Death & Differentiation CrossRef
5. Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling
   Yu Gan et al, 2017, Oncology Letters CrossRef
6. Characterization of Novel Progression Factors in Castration-Resistant Prostate Cancer Based on Global Comparative Proteome Analysis
   Ann-Yae Na et al, 2021, Cancers CrossRef
7. Integrated Powered Density: Screening Ultrahigh Dimensional Covariates with Survival Outcomes
   Hyokyoung G. Hong et al, 2018, Biometrics CrossRef
8. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells
   Quanfeng Ma et al, 2020, BioMed Research International CrossRef
9. CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS
   Yalçın ERZURUMLU et al, 2023, Ankara Universitesi Eczacilik Fakultesi Dergisi CrossRef
10. Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma
    Khalid Ahmed et al, 2024, Scientific Reports CrossRef